Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct:264:1-9.
doi: 10.1016/j.ahj.2023.05.025. Epub 2023 Jun 8.

Temporal Changes in Clinical Characteristics and Outcomes of Adults With Congenital Heart Disease

Affiliations

Temporal Changes in Clinical Characteristics and Outcomes of Adults With Congenital Heart Disease

Alexander C Egbe et al. Am Heart J. 2023 Oct.

Abstract

Background: The purpose of this study was to assess differences in the clinical characteristics (defined by congenital heart disease [CHD] anatomic and physiologic classification scheme) of adults with CHD across different eras, and how these differences influence outcomes (heart failure hospitalization and all-cause mortality).

Method: Patients were divided into depending on year of baseline encounter: cohort #1 (1991-2000, n = 1,984 [27%]), cohort #2 (2001-2010, n = 2,448 [34%]), and cohort #3 (2011-2020, n = 2,847 [39%]). Patients were classified into 3 anatomic groups (simple, moderate, and complex CHD) and 4 physiologic stages (stage A-D).

Results: There was a temporal increase in the proportion of patients in physiologic stage C (17% vs 21% vs 24%, P < .001), and stage D (7% vs 8% vs 10%, P = .09), with a corresponding decrease in physiologic stage A (39% vs 35% vs 28%, P < .001). No temporal change in anatomic groups. There was a temporal decrease in the incidence of all-cause mortality (12.7 vs 10.6 vs 9.5 per 1,000 patient-years, P < .001). However, there was a temporal increase in the incidence of heart failure hospitalization (6.8 vs 8.4 vs 11.2 per 1,000 patient-years, P < .001). CHD physiologic stage (but not anatomic groups) was associated with heart failure hospitalization and all-cause mortality.

Conclusions: There is a need for better strategies to identify and treat heart failure, and to modify the risk factors associated with heart failure and all-cause mortality.

PubMed Disclaimer

Conflict of interest statement

Disclosures None.

Figures

Figure 1 A/B:
Figure 1 A/B:
Bar graphs comparing the incidence of heart failure hospitalization (A) and all-cause mortality (B) between the patients that had their baseline encounter in 1991–2000 (Cohort #1), 2001–2010 (Cohort #2), and 2011–2020 (Cohort #3). N signifies the number of patients in each cohort. P values signify comparison across the 3 groups.

References

    1. Mandalenakis Z, Rosengren A, Skoglund K, Lappas G, Eriksson P and Dellborg M. Survivorship in Children and Young Adults With Congenital Heart Disease in Sweden. JAMA Intern Med. 2017;177:224–230. - PubMed
    1. Mandalenakis Z, Giang KW, Eriksson P, Liden H, Synnergren M, Wahlander H, Fedchenko M, Rosengren A and Dellborg M. Survival in Children With Congenital Heart Disease: Have We Reached a Peak at 97%? J Am Heart Assoc. 2020;9:e017704. - PMC - PubMed
    1. Lopez KN, Morris SA, Sexson Tejtel SK, Espaillat A and Salemi JL. US Mortality Attributable to Congenital Heart Disease Across the Lifespan From 1999 Through 2017 Exposes Persistent Racial/Ethnic Disparities. Circulation. 2020;142:1132–1147. - PMC - PubMed
    1. Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, Xu P, Correa A, Jenkins K and Marelli AJ. Congenital Heart Defects in the United States Estimating the Magnitude of the Affected Population in 2010. Circulation. 2016;134:101.-+. - PMC - PubMed
    1. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N and Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130:749–56. - PubMed

Publication types